Barros-Silva observed that HER2 amplification was not notably correlated with gender, age, vascular tumor thrombus, lymph node metastasis or clinical staging in patients with GC (28). This evidence concerns the gene ERBB2 and metastatic malignant neoplasm in the lymph nodes.